Caris Life Sciences, Inc. (CAI)
23.04
-0.92
(-3.84%)
USD |
NASDAQ |
Nov 13, 16:00
23.04
0.00 (0.00%)
After-Hours: 19:59
Caris Life Sciences Total Liabilities (Quarterly) : 616.14M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 616.14M |
| June 30, 2026 | 637.89M |
| March 31, 2026 | 568.90M |
| December 31, 2025 | 548.36M |
| Date | Value |
|---|---|
| September 30, 2025 | 506.21M |
| June 30, 2025 | 502.15M |
| March 31, 2025 | 645.34M |
| December 31, 2024 | 620.92M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Natera, Inc. | 878.86M |
| Myriad Genetics, Inc. | 340.20M |
| BioRestorative Therapies, Inc. | 1.615M |
| CareDx, Inc. | 174.00M |
| Exagen, Inc. | 41.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.256B |
| Shareholders Equity (Quarterly) | 639.48M |
| Debt to Equity Ratio | 0.7241 |
| Current Ratio | 6.715 |
| Net Debt Paydown Yield | -0.10% |